Company intelligence / Profile preview

ABANZA

Aranguren, Navarra, Spainabanzamed.com ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

ABANZA has developed and commercialized the WasherCap™ Fixation System, which has received FDA clearance for soft tissue graft fixation in procedures such as ACL reconstruction. Preliminary clinical use by select surgeons has shown promising results, but broader clinical validation is ongoing. The company is preparing to expand its product line with the WasherCap™ Mini for additional joint repairs.

Therapeutic areas: OtherRheumatology
Modalities: DeviceMedical device (soft tissue fixation systems)
Industry: Surgical Medical Devices

Partnerships

Distribution networks across Europe and Latin America are mentioned but not named specifically.

Beyond the preview

Go deeper on ABANZA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABANZA.

Explore the full profile